Federated Hermes’s Translate Bio, Inc. Common Stock TBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-3,738,001
| Closed | -$103M | – | 2372 |
|
|
2021
Q2 | $103M | Buy |
3,738,001
+34,650
| +0.9% | +$681K | 0.19% | 143 |
|
|
2021
Q1 | $61.1M | Buy |
3,703,351
+960,972
| +35% | +$21.9M | 0.12% | 226 |
|
|
2020
Q4 | $50.5M | Buy |
2,742,379
+82,464
| +3% | +$1.48M | 0.1% | 249 |
|
|
2020
Q3 | $36.2M | Buy |
2,659,915
+1,816
| +0.1% | +$28K | 0.08% | 273 |
|
|
2020
Q2 | $47.6M | Buy |
2,658,099
+368,937
| +16% | +$5.56M | 0.12% | 201 |
|
|
2020
Q1 | $22.8M | Buy |
2,289,162
+192,634
| +9% | +$1.58M | 0.07% | 314 |
|
|
2019
Q4 | $17.1M | Buy |
2,096,528
+49,753
| +2% | +$459K | 0.04% | 455 |
|
|
2019
Q3 | $20.3M | Buy |
2,046,775
+916,775
| +81% | +$8.66M | 0.05% | 366 |
|
|
2019
Q2 | $14.3M | Hold |
1,130,000
| – | – | 0.03% | 458 |
|
|
2019
Q1 | $11.5M | Hold |
1,130,000
| – | – | 0.03% | 513 |
|
|
2018
Q4 | $8.47M | Buy |
1,130,000
+330,000
| +41% | +$2.42M | 0.02% | 554 |
|
|
2018
Q3 | $8M | Buy |
800,000
+89,805
| +13% | +$1.05M | 0.02% | 655 |
|
|
2018
Q2 | $8.98M | Buy |
+710,195
| New | +$8.58M | 0.03% | 491 |
|
Federated Hermes's TBIO Position: Q3 2021 in Review
Federated Hermes sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 3,738,001 shares — an estimated $103M sold.
Federated Hermes first reported a position in TBIO in Q2 2018 and held it in 13 quarters. The position peaked at $103M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.
- Federated Hermes reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
- Federated Hermes sold 3,738,001 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $103M.
- Federated Hermes first reported a position in Translate Bio, Inc. Common Stock in Q2 2018 and held it in 13 quarters.
- Federated Hermes's Translate Bio, Inc. Common Stock position peaked at $103M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.
Based on Federated Hermes's 13F filing for Q3 2021, filed 15 Nov 2021.